Meet the leaders and members of the Molecular Biology and Cancer Genetics research program at the OSUCCC – James who promote improved screening, diagnosis, prognosis and treatment.

Leaders

Matthew Ringel, MD

Dr. Ringel's research interests include molecular mechanisms involved in thyroid cancer invasion and metastasis; with an active interest in new drug testing for thyroid cancer therapy.

Read More

Philip Tsichlis, MD

At The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J.

Read More

Members

Mohamed Abdel-Rahman, MD, PhD

Mohamed Abdel-Rahman, MD, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where he focuses his research on molecular diagnosis of ocular melanoma, identification of novel targets for ocular melanoma therapy and hereditary predisposition to ocular

Read More

Rene Anand, MS, PhD

As a member of the Molecular Biology and Cancer Genetics team at the OSUCCC – James, Rene Anand, PhD, along with his laboratory, has recently developed human adult stem cell (iPSC) derived models of cancer, autism and Alzheimer’s disease. In particular, Dr. Anand’s work focuses on understanding.

Read More

Paul Andreassen, PhD

Paul Andreassen, PhD, is a member of the OSUCCC – James Molecular Biology and Cancer Genetics Program. He is based at Cincinnati Children’s Hospital Medical Center.

Read More

Rami Aqeilan, PhD

Rami Aqeilan, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James. His work explores the molecular aspect of cancer biology in an effort to uncover the genes that contribute to transforming an incipient cancer cell.

Read More

Kellie Archer, PhD

Kellie Archer, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James and chair of the Division of Biostatistics in The Ohio State University College of Public Health. Her work focuses on developing statistical methods and software to analyze data from.

Read More

Bruce Aronow, PhD

As a member of the OSUCCC – James Molecular Biology and Cancer Genetics Program, Bruce Aronow, PhD, works with investigators in diverse areas to use technologies that measure gene activity, variation and mutation across the genome. He is based at Cincinnati Children’s Hospital Medical Center.

Read More

Colleen Cebulla, MD, PhD

Colleen Cebulla, MD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where her research is focused on retinal detachments and uveal melanoma. Her research team has identified that over 10 percent of patients with uveal melanoma have a heritable cancer.

Read More

Dawn Chandler, PhD

Dawn Chandler, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where her work focuses on the regulation of pre-mRNA splicing and how its disruption can lead to pediatric diseases such as cancer. In one recent study, her team’s research identified.

Read More

Mathew Cherian, MBBS

Dr. Cherian specializes in the clinical care of patients with breast cancer and in using molecular techniques to dissect the pathogenesis of cancer. His current research interests include: the pathogenesis of endocrine resistance in metastatic breast cancer and the design of therapies to target.

Read More

Lionel Chow, MD, PhD

Lionel Chow, MD, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where his research focuses on glioblastoma multiforme and angiosarcoma. Dr. Chow’s work has led to the development of robust laboratory models for this disease that are now used to.

Read More

Susan Cole, PhD

The Notch signaling pathway plays key roles in human development and disease. Disregulation of Notch signaling is frequently seen in human cancers, for instance, activating Notch mutations are seen in over 50% of juvenille T-ALL cases.

Read More

Vincenzo Coppola, MD

Vincenzo Coppola, MD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James. He is also the director of the Genetically Engineered Mouse Modeling Core (GEMMC) Shared Resource to assist other OSUCCC members in generating mouse models of human cancer and to study.

Read More

Carlo Croce, MD

Dr. Croce studies the molecular changes in genes that lead to cancer. He is particularly interested in the early changes of malignancy and how they might serve as targets for new treatment and preventive agents.

Read More

Biplab Dasgupta, PhD

Biplab Dasgupta, PhD, a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, is based at Cincinnati Children’s Hospital Medical Center. His research seeks to learn how neural cell/stem-cell metabolic and energy status is linked to cell cycle, lineage commitment.

Read More

Albert de la Chapelle, MD, PhD

Research in Dr. de la Chapelle’s laboratory focuses on the mapping, cloning, and characterization of high- and low-penetrance genes for cancer predisposition. When new genes are identified, studies are directed to determine the pathophysiological role of the proteins or RNA molecules they encode.

Read More

Nicholas Denko, MD, PhD

Nicholas Denko, MD, PhD, a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, is the co-holder of two U. S.

Read More

Soledad Fernandez, PhD

I am a Professor in the department of Biomedical Informatics. I currently serve in the role of Vice Chair for Collaborative Research in this department.

Read More

Harold Fisk, PhD

Centrosomes are microtubule-organizing structures that coordinate mitotic spindle assembly and chromosome segregation. Centrosome aberrations are found in a variety of tumors, and are associated with tumorigenesis in breast cancer, prostate cancer, and leukemia.

Read More

Michael Freitas, PhD

Michael Freitas, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where he focuses his research on proteomics. He also is involved in biomarker discovery and validation, as well as bioinformatics for mass spectrometry-based proteomics.

Read More

Ramesh Ganju, PhD

Ramesh Ganju, PhD, is a professor and vice chair of experimental pathology in the Department of Pathology at Ohio State, where he is also a researcher in the Molecular Biology and Cancer Genetics Program at the OSUCCC – James. The major focus of Dr. Ganju’s laboratory is to elucidate.

Read More

Samir Ghadiali, PhD

As part of an NSF funded project, Dr. Ghadiali uses engineering, biophysical and molecular/cell biology techniques to identify how biomechanical properties of both cancer cells and the tumor microenvironment (TME) influence oncogenic epithelial to mesenchymal transition (EMT). Dr. Ghadiali also.

Read More

Hazem Ghoneim, PhD

Hazem Ghoneim, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where he focuses his research on understanding the epigenetic programming of T-cells during infection and cancer. Dr. Ghoneim seeks to develop a conceptual understanding of how.

Read More

Venkat Gopalan, PhD

My laboratory has a long-standing interest in RNase P, an endonuclease involved in tRNA 5’- biogenesis. Human RNase P (nuclear) employs a protein-aided ribozyme to process precursortRNAs and long non-coding RNAs (lncRNAs).

Read More

John Gunn, PhD

John Gunn, PhD, is a professor in the Department of Microbial Infection and Immunity at Ohio State and a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where his research centers on microbial resistance to innate immunity. In particular, he is focused on the.

Read More

Tsonwin Hai, PhD

Tsonwin Hai, PhD, is a professor in the Department of Biological Chemistry and Pharmacology at Ohio State, and a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James. Her research team focuses on maladaptive processes in the development of disease, with a focus on.

Read More

Paul Herman, PhD

Dr. Herman's lab is interested in understanding the mechanisms Herman Lab Memberscontrolling eukaryotic cell growth and proliferation. The primary focus has been on the G0-like resting states that cells enter when conditions are not conducive to continued growth.

Read More

Feng Hong, MD, PHD

Dr. Hong is studies the crosstalk between unfolded protein response (UPR) and cancer. The UPR is a critical protein quality control mechanism that is involved in physiological homeostasis and diseases.

Read More

Willa Hsueh, MD

At The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J.

Read More

F. Kay Huebner, PhD

Kay Huebner, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where her research focuses on investigating and defining the biological functions of tumor-suppressor proteins. In particular, she is interested in two of the most frequently inactivated.

Read More

Jaime Imitola, MD

A member of the OSUCCC – James Molecular Biology and Cancer Genetics Program, Jaime Imitola, MD, directs the Neural Stem Cell Laboratory. His work focuses on understanding the molecular mechanisms involving cross talk between the immune system and neural stem cells genomics in models of multiple.

Read More

Sissy Jhiang, PhD

Sissy Jhiang, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where her research focuses on molecular biology, cellular biology, genetic-engineered animal models, small-animal imaging modalities and nanobiotechnology. In particular, she is exploring.

Read More

Daniel Jones, MD, PhD

Dr. Jones' research interests center on models for mouse models, functional screens and classification approaches for attributing oncogenic and tumor potential of mutations identified in genomic screens and clinical sequencing assays. Specific model system are PTEN-haploinsufficient colon cancer.

Read More

Tatiana Kalin, MD, PhD

multiple transgenic and knockout mouse models to study the specific role of several transcription factors in different cell populations, including lung epithelial cells, macrophages, fibroblasts, pericytes and endothelial cells. My laboratory is interested in identifying critical regulatory.

Read More

Lawrence Kirschner, MD, PhD

Lawrence Kirschner, MD, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where his research focuses on endocrine tumor genetics. He is particularly interested in understanding how dysregulation of PKA contributes to tumorigenesis in cAMP-responsive.

Read More

Ashish Kumar, MD, PhD

Ashish Kumar, MD, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, and is based at Cincinnati Children’s Hospital Medical Center. His research focuses on blood cancers of childhood, specifically infant leukemia, and Langerhans Cell Histiocytosis.

Read More

Takeshi Kurita, PhD

Takeshi Kurita, PhD, is a member of the OSUCCC – James Molecular Biology and Cancer Genetics Program. His research explores the molecular mechanisms of development and carcinogenesis of the reproductive organs.

Read More

Krista La Perle, DVM, PhD

Dr. La Perle is Professor and Director of the Comparative Pathology & Mouse Phenotyping Shared Resource at Ohio State University. Her BS/DVM are from North Carolina State University and postdoctoral pathology training/PhD from OSU.

Read More

Nam Yong Lee, PhD

Nam Young Lee, PhD, is a member of the OSUCCC – James Molecular Biology and Cancer Genetics Program. Dr. Lee’s research explores how transforming growth factor beta signaling regulates vascular functions during tumor development and metastasis.

Read More

Jennifer Leight, PhD

As a member of the Molecular Biology and Cancer Genetics Program at OSUCCC – James, Jennifer Leight, PhD, uses innovative biomaterials to investigate fundamental questions regarding the tumor microenvironment and the regulation of cancer cell function. She has also developed new methods for.

Read More

Stephen Lessnick, MD, PhD

As Director of the Center for Childhood Cancer and Blood Disorders at Nationwide Children's Hospital, Dr. Lessnick leads a team of pediatric researchers who are working to expand the understanding of the development of childhood cancer and to transform diagnostic and treatment strategies. He also.

Read More

Lang Li, PhD

I have two cancer related research areas. In the first area, I use electronic medical record data sources and medical informatics approaches to investigate risk factors that predict either drug efficacy or adverse drug events.

Read More

Zaibo Li, MD, PhD

Zaibo Li, MD, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where his research focuses on breast and gynecologic pathology. In particular, he is interested in breast cancer biomarkers, especially HER2 and checkpoint immune markers, as well as.

Read More

Q Richard Lu, PhD

Dr. Lu's lab has identified a novel tumor suppressor gene GNAS in medulloblastoma and defined an oncogenic role of Olig2 in glioma initiation and progression. Their research goal is to identify the critical molecules and pathways that drive tumorigenesis in glioblastoma and medulloblastoma, and.

Read More

Qin Ma, PhD

Qin Ma, PhD, is an associate professor in the Department of Biomedical Informatics at The Ohio State University and a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where he studies how diverse cells impact cancer development. One of Dr. Ma’s current.

Read More

K John McLaughlin, PhD

K. John McLaughlin, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where his research focuses on epigenetics, stem cells and therapeutic transplant models.

Read More

Wayne Miles, PhD

Wayne Miles, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where his research seeks to identify mechanisms that enable cancer cells to overcome cellular stresses associated with oncogenic growth. In particular, he is focused on how the loss of the.

Read More

Eugene Oltz, PhD

Dr. Oltz studies the genetic, epigenetic, and topological mechanisms that govern gene expression programs in normal and transformed lymphocytes. Insights from these studies are being leveraged to create targeted epigenetic therapeutics for cancer and autoimmunity.

Read More

Jose Otero, MD, PhD

Jose Otero, MD, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where his research focuses on induced pluripotent stem cells, neural stem cells, cell-cycle control of stem cells and molecular diagnostics. One of his recent studies showed a promising.

Read More

Ioanna Papandreou, PhD

Ioanna Papandreou, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where her research focus is on identifying new metabolic targets for therapeutic development. In particular, she seeks to understand how cells in solid tumors respond to.

Read More

Jeffrey Parvin, MD, PhD

Jeffrey Parvin, MD, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where his research focuses on biological processes in breast cancer. In particular, he investigates the pathways regulated by the BRCA1 tumor-suppressor proteins, as well as the.

Read More

Yuri Pekarsky, PhD

Yuri Pekarsky, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where his research focuses on mature T-cell leukemia chromosomal rearrangements. Through the investigation of one chromosomal rearrangement, two related genes—TCL1 and TCL1b—have been.

Read More

Ruben Petreaca, PhD

Ruben Petreaca, PhD is a member of the OSUCCC – James Molecular Biology and Cancer Genetics Program. He is based at the OSU Marion campus.

Read More

John Phay, MD

As a member of the OSUCCC – James Molecular Biology and Cancer Genetics Program, John Phay, MD, focuses his research on treatments for thyroid cancer. He is the co-holder of European and U.

Read More

Kamal Pohar, MD

Dr. Pohar’s research interest include: Bladder cancer, Testicular cancer, Genetic and epigenetic changes contributing to progression of bladder cancer, and Developing clinical and biologic databases in bladder cancer.

Read More

Shaurya Prakash, PhD

Dr. Prakash has two main research interests. Both are driven by engineering principles for developing new technological solutions for (a) fundamental understanding, (b) new diagnostic tools, and (c) new instrumentation for improving treatment outcomes.

Read More

Nancy Ratner, PhD

Nancy Ratner, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where she focuses on identifying novel therapies for diseases of the nervous system. In particular, she investigates interactions between glial cells and axons in the development of the.

Read More

Eduardo Reategui, PhD

The Reátegui research group focuses on the development of microtechnology platforms for the isolation and characterization of circulating tumor biomarkers for cancer diagnostics and therapeutics. Circulating biomarkers are currently extensively studied in the cancer research field because of their.

Read More

Grzegorz Rempala, PhD

Grzegorz Rempala, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where his research focuses on mathematical methods relevant to clinical treatment as well as public health. One of his recent projects has potential clinical relevance as it details.

Read More

Thomas Scharschmidt, MD

Thomas Scharschmidt, MD, is a member of the Molecular Biology and Cancer Genetics Program at OSUCCC – James, where his research focuses on adjuvant chemotherapy for management of soft tissue and bone sarcomas. He also investigates outcomes of limb reconstructions, oncology implant design.

Read More

Daniel Schoenberg, PhD

Daniel Schoenberg, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where he focuses his research on fundamental mechanisms of post-transcriptional gene regulation and the application of this knowledge to cancer and inherited diseases. His current.

Read More

Nilay Shah, MD

Nilay Shah, MD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where his research focuses on embryonic cancers, particularly neuroblastomas. Dr. Shah seeks to identify biomarkers of disease severity to better distinguish between low-risk patients who.

Read More

Amanda Simcox, PhD

Amanda Simcox, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where she studies epidermal growth factor receptor signaling. In particular, Dr. Simcox seeks to decipher the gene regulatory network in a just-hatched larva that grows from about 30.

Read More

Gina Sizemore, PhD

Research in the Sizemore lab integrates in vitro and in vivo modeling of the brain metastatic tumor microenvironment (TME) to provide mechanistic insight into how the brain metastatic TME contributes to breast cancer metastatic progression. Current studies aim to elucidate whether platelet derived.

Read More

Steven Sizemore, PhD

Dr. Sizemore's research focuses on elucidating the mechanisms of cancer metastasis and developing novel therapies to improve outcomes for patients with metastatic disease. Metastatic breast cancer and metastatic soft tissue sarcoma are the areas of concentration for his research which combines.

Read More

Aleksander Skardal, PhD

Dr. Skardale's lab employs biofabrication, biomaterials, and tissue engineering technologies to develop in vitro 3D cancer models for drug screening, disease modeling, mechanistic probing, and personalized medicine. They have created patient biospecimen-derived organoids for personalized drug.

Read More

Jonathan Song, PhD

Jonathan Song, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where he brings an engineering perspective. In particular, Dr. Song uses microscale engineering technology to reconstitute the microarchitecture of living tissue in vitro to investigate.

Read More

Paul Stoodley, BSc(Hons), PhD

Dr. Paul Stoodley is Director of the Microscopy Shared Resource and Professor in the Departments of Microbial Infection and Immunity and Orthopaedics. He has a broad background in the use of microscopy to study clinical specimens.

Read More

Anne Strohecker, PhD

As a member of the OSUCCC – James Molecular Biology and Cancer Genetics Program, Anne Strohecker, PhD, seeks to enhance the understanding of autophagy and uncover new therapeutic targets for cancer. Her research focuses on the identification of novel autophagy regulators, their functional.

Read More

Vish Subramaniam, PhD

Vish Subramaniam, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where he brings an engineering perspective to his research on the interactions between low-frequency electromagnetic waves and tissues and cells. This research ranges from fundamental.

Read More

Matthew Summers, PhD

Dr. Summers' research focuses on the mechanisms of genome maintenance, in particular understanding altered or heightened responses to stress occurring during replication or mitosis in transformed cells. His lab strives to gain novel insight into these differences in order to improve the treatment.

Read More

Monica Venere, PhD

The overarching goal of Dr. Venere's laboratory is to elucidate points of fragility for glioblastoma using cell and molecular biology as well as animal models and exploit these findings to develop new treatment modalities and/or improve on current standard of care therapies and thereby alter

Read More

Jing Jenny Wang, PhD

Research in the Wang laboratory includes basic and translational research projects, aiming to 1) understand the molecular mechanisms of colorectal cancer metastasis, recurrence, tumor dormancy and drug resistance, 2) identify and validate novel therapeutic targets using cell culture, organoids,

Read More

Ruoning Wang, PhD

Ruoning Wang, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James. His research explores the impact of the interplay between nutrients-mediated metabolic programs and cellular-signaling cascades on cancer cells (particularly pediatric cancer) and immune.

Read More

Robin Wharton, PhD

Robin Wharton, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where he focuses his research on post-transcriptional gene regulation during development in the germline of the model system Drosophila melanogaster. Several of his recent projects.

Read More

Terence Williams, MD, PhD

As a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, Terrence Williams, MD, PhD, focuses his research primarily on thoracic and gastrointestinal malignancies and thyroid cancer. Dr. Williams’ laboratory focuses on DNA damage response pathways, radiation and.

Read More

Richard Wilson, PhD

D. Wilson is interested in utilizing the tools & technologies of modern genomics, and developing new derivatives thereof, to ask and answer questions of cancer biology that have eluded previous researchers.

Read More

Jian-Qiu Wu, PhD

Jian-Qiu Wu, PhD, is a member of the OSUCCC – James Molecular Biology and Cancer Genetics Program, where his research focuses on cellular processes related to the two defining characteristics of cancer: uncontrolled cell division and metastasis. In particular, his work centers on the.

Read More

Li Wu, PhD

As a member of the College of Veterinary Medicine and College of Medicine at The Ohio State University, Li Wu, PhD, brings a special perspective to the OSUCCC – James Molecular Biology and Cancer Genetics Program. Dr. Wu is an internationally recognized molecular virologist studying HIV.

Read More

Sung Yoon, PhD

Sung Yoon, PhD, is a member of the Molecular Biology and Cancer Genetics Program at OSUCCC – James, where her research focuses on understanding how the balance between cell survival and death is maintained in the adult nervous system. In particular, she is exploring the role of stress kinase JNK.

Read More

Jacob Yount, PhD

Jacob Yount, PhD, is a member of the Molecular Biology and Cancer Genetics Program at OSUCCC – James, where his research focuses on developing and implementing tools to study protein post-translational modifications. In particular, he explores protein lipidations such as palmitoylation.

Read More

Junran Zhang, MD, PHD

The focus of Dr. Zhang's research is to study the DDR and to investigate how DDR can be exploited for personalized medicine. The DNA damage can be caused indirectly or directly by ionizing radiation (IR), replication stress-generating chemotherapeutic drugs, targeted therapy agents and.

Read More

Yan Zhang, PhD

Yan Zhang, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where her research focuses on high-throughput genomic and proteomic data generated in cancer studies. In particular, she is interested in integrating multiple data types to identify.

Read More

Weiqiang Zhao, MD, PhD

Dr. Zhao's research interest include investigating and validating biomarkers in molecular pathogenesis, diagnosis, and target intervention in cancer and leukemia. One of his projects is to study the role of isoform 6 of IKZF1 gene in leukemia or lymphoma progression which has been shown to be.

Read More

Jian Zhu, PhD

Jian Zhu, PhD, is an associate professor in the Department of Pathology at The Ohio State University and a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where his research focuses primarily on HIV-persistent infections, HIV-associated malignancies and

Read More

Please enter a keyword (i.e. Name, Research Interest) or choose a Research Program

OR

Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator

OR

Find a Scientific Publication

Search for Clinical Trials